百合医疗Baihe品牌怎么样 申请店铺

我要投票 百合医疗Baihe在医疗器械行业中的票数:654 更新时间:2026-01-03
百合医疗Baihe是哪个国家的品牌?「百合医疗Baihe」是 广东百合医疗科技股份有限公司 旗下著名品牌。该品牌发源于广东省佛山市,由创始人黄 *在1999年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力百合医疗Baihe品牌出海!将品牌入驻外推网,定制百合医疗Baihe品牌推广信息,可以显著提高百合医疗Baihe产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

百合医疗Baihe怎么样

广东百合医疗科技股份有限公司,创办于1999年,位于佛山市南海区狮山镇桃园东路89号。公司主营业务为一次性使用医用耗材等医疗器械的研发、生产和销售,是一家现代工程技术和临床医学相结合的企业,是国内高端医用耗材领域能够与国外产品形成强有力竞争的为数不多的企业之一。

公司拥有国内先进的医用耗材生产工艺和技术,完善的质量保证体系,现代化的管理手段以及高品质的产品和优质的服务。从公司创立之初的中心静脉导管和血液透析导管起步,截止目前,公司已经形成静脉输液耗材、血液净化耗材、护创敷料耗材三大领域,并依托三大领域的技术优势和丰富的产品储备,成为上述领域内的一次性使用医用耗材综合解决方案提供商。

公司聚集了由陈建华等医用耗材专家领衔的高水平专业研发和技术创新团队,人才储备充足,专业涵盖医用高分子材料、生物医学工程、临床医学、检验医学、生命科学、生物化学、材料学、模具、机械等多个学科。公司主要产品有:中心静脉导管、血液透析导管、输液接头、延长管、旋塞、留置针、血液回路、内瘘穿刺包、压力传感器等三类医疗器械。

产品已经销往世界各地,其中中心静脉导管及血液透析导管两个主导产品国内市场占有率均较高。

公司获得包括华南理工大学、暨南大学、中山大学附属医院、南方医科大学珠江医院等院校及各级政府机构和社会各界的关注和支持,使得百合医疗对医用导管产品的基础研究和临床试用得以顺利开展,并取得长足进步。

公司将继续秉承“注重信誉,对生命负责;追求卓越,让顾客满意”的价值观,坚持以“用户为中心”的设计理念,继续致力于一次性使用医用耗材等医疗器械的研发、生产和销售。公司将本着“为患者负责”的精神,精益求精,争取早日跻身世界领先的一次性使用医用耗材综合解决方案提供商行列。


Guangdong Baihe Medical Technology Co., Ltd., founded in 1999, is located at No. 89, Taoyuan East Road, Shishan town, Nanhai District, Foshan City. The main business of the company is the research and development, production and sales of disposable medical consumables and other medical devices. It is an enterprise combining modern engineering technology and clinical medicine, and one of the few enterprises in the domestic high-end medical consumables field that can form strong competition with foreign products. The company has advanced production technology and technology of medical consumables, perfect quality assurance system, modern management means, high-quality products and high-quality services. From the beginning of the company's establishment, the central venous catheter and hemodialysis catheter started. Up to now, the company has formed three major fields: intravenous infusion consumables, blood purification consumables and nursing wound dressing consumables. Relying on the technical advantages and rich product reserves of the three fields, the company has become a comprehensive solution provider of disposable medical consumables in the above fields. The company has gathered a high-level professional R & D and technical innovation team led by Chen Jianhua and other medical consumables experts, with sufficient talent reserve, covering medical polymer materials, biomedical engineering, clinical medicine, laboratory medicine, life science, biochemistry, materials science, mold, machinery and other disciplines. The company's main products are: central venous catheter, hemodialysis catheter, infusion connector, extension tube, cock, indwelling needle, blood circuit, internal fistula puncture bag, pressure sensor and other three types of medical devices. The products have been sold all over the world, and the two leading products of central venous catheter and hemodialysis catheter have a high market share in China. The company has obtained the attention and support from colleges and universities including South China University of technology, Jinan University, Affiliated Hospital of Sun Yat sen University, Pearl River Hospital of Southern Medical University, as well as government agencies at all levels and all sectors of the society, which makes Lily medical carry out the basic research and clinical trial of medical catheter products smoothly and make great progress. The company will continue to adhere to the values of "pay attention to reputation, be responsible for life; pursue excellence, make customers satisfied", adhere to the design concept of "user centered", and continue to be committed to the research, development, production and sales of disposable medical consumables and other medical devices. In the spirit of "being responsible for patients", the company will strive for perfection and become one of the world's leading providers of comprehensive solutions for disposable medical consumables as soon as possible.

本文链接: https://brand.waitui.com/c48592003.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

印度政府批准电子元件制造计划下的投资金额为4186.3亿卢比

印度政府批准电子元件制造计划下的投资金额为4186.3亿卢比。(财联社)

2小时前

分析师:三星SDI或将持续亏损直至2026年底

NH Investment & Securities以Ju Min-woo为首的分析师表示,三星SDI在2025年第四财季因美国电动汽车需求疲软而录得大于预期的亏损后,可能会持续亏损直至2026年底。这些分析师表示,由于在欧洲的电动汽车电池市场份额不断下滑,这家韩国电池制造商可能比竞争对手受到更大冲击。NH Investment & Securities预计,该公司第四财季将录得3,387亿韩元的营业亏损,而市场平均预期为亏损2,690亿韩元,并预计其2025年年度亏损为1.765万亿韩元。NH Investment & Securities预测,该公司2026年的营业亏损可能收窄至9,670亿韩元。(新浪财经)

2小时前

葡萄牙12月特斯拉新车注册量同比下降12.7%,2025年累计下降22.3%

据葡萄牙汽车协会(ACAP),葡萄牙12月特斯拉新车注册量同比下降12.7%,2025年累计下降22.3%。(财联社)

2小时前

元旦假期首日,全社会跨区域人员流动量超2亿人次

2026年1月1日,全社会跨区域人员流动量20747.5万人次,环比下降0.1%,同比增长20.3%。(央视新闻)

2小时前

挪威2025年新车销量的96%为电动汽车

上周五的官方数据显示,去年在挪威注册的几乎所有新车都是纯电动汽车,其中特斯拉的销量更是一路飙升,使这个北欧国家在逐步淘汰汽油和柴油动力汽车方面巩固了全球领先地位。在税收优惠政策的推动下,2025年注册的所有新车中有95.9%是电动汽车,12月份这一数字接近98%。挪威道路联合会(OFV)的数据显示,这一年度数字高于2024年的88.9%。OFV称,挪威今年登记的新车数量达到创纪录的179549辆,比2024年增长了40%。(新浪财经)

2小时前

本页详细列出关于百合医疗Baihe的品牌信息,含品牌所属公司介绍,百合医疗Baihe所处行业的品牌地位及优势。
咨询